Browse the full directors' dealings record of 艾迪药业, a listed equity based in France. Shares trade on FR FR, under the oversight of AMF. Operating in the Health Care sector, 艾迪药业 has logged 12 public disclosures. Market capitalisation: €6.9bn. The latest transaction was reported on 2 June 2026 (Purchase). Among the most active insiders: 傅和亮. Every trade is openly available.
12
Insider Decl.
0
Thresholds
·
11 ops.
Buy Volume
·
1 ops.
Sell Volume
21Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
